Last reviewed · How we verify

ChiNing decoction — Competitive Intelligence Brief

ChiNing decoction (ChiNing decoction) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: herbal decoction / traditional Chinese medicine. Area: Oncology.

phase 3 herbal decoction / traditional Chinese medicine Oncology Small molecule Live · refreshed every 30 min

Target snapshot

ChiNing decoction (ChiNing decoction) — Tianjin Medical University Cancer Institute and Hospital. ChiNing decoction is a traditional Chinese medicine formulation that enhances immune function and inhibits tumor growth through multi-component herbal synergy.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ChiNing decoction TARGET ChiNing decoction Tianjin Medical University Cancer Institute and Hospital phase 3 herbal decoction / traditional Chinese medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (herbal decoction / traditional Chinese medicine class)

  1. Tianjin Medical University Cancer Institute and Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ChiNing decoction — Competitive Intelligence Brief. https://druglandscape.com/ci/chining-decoction. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: